Optimum Investment Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Optimum Investment Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-100	Closed	-$22K	–	996
2021 Q1	$22K	Hold	100	–	–	0.01%	651
2020 Q4	$12K	Hold	100	–	–	﹤0.01%	712
2020 Q3	$10K	Hold	100	–	–	﹤0.01%	702
2020 Q2	$12K	Hold	100	–	–	﹤0.01%	680
2020 Q1	$9K	Hold	100	–	–	﹤0.01%	706
2019 Q4	$10K	Buy	+100	New	+$11.2K	﹤0.01%	781
2018 Q4	–	Sell	-300	Closed	-$52K	–	1060
2018 Q3	$52K	Buy	+300	New	+$43.3K	0.01%	525
2015 Q1	$50K	Hold	550	–	–	0.02%	513
2014 Q4	$37K	Buy	+550	New	+$40.2K	0.01%	577

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Optimum Investment Advisors's GWPH Position: Q2 2021 in Review

Optimum Investment Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 100 shares — an estimated $22K sold.

Optimum Investment Advisors first reported a position in GWPH in Q4 2014 and held it in 9 quarters. The position peaked at $52K in Q3 2018. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Optimum Investment Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Optimum Investment Advisors sold 100 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $22K.
Optimum Investment Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2014 and held it in 9 quarters.
Optimum Investment Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $52K in Q3 2018.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Optimum Investment Advisors's 13F filing for Q2 2021, filed 2 Aug 2021.